Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
The feature you requested does not exist. However, we suggest the following feature:

Coronavirus: U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mozambique

09/27/2021 | 04:33am EDT

MAPUTO, Mozambique, September 24, 2021/APO Group/ -- Today, at the Mavalane International Airport in Maputo, the United States government donated 336,000 doses of the Johnson & Johnson COVID-19 vaccine to the Mozambican Ministry of Health. Because the vaccine confers immunity in a single dose, this shipment will provide immunity to 336,000 Mozambicans, protecting the health of Mozambicans and preventing dangerous new variants from spreading. Since the storage of Johnson & Johnson vaccines is less onerous than other vaccines, they are easier to distribute.

Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique

U.S. Ambassador Dennis W. Hearne stated: "As the largest bi-lateral donor of vaccines to Mozambique, the United States is pleased to be part of this coordinated global effort to bring life-saving support to the people of Mozambique. Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique. These vaccines will fill an important need to successfully fight the virus."

This is the second COVID-19 vaccine delivery. In July, the United States donated 302,400 Johnson and Johnson vaccines. This assistance is another example of the strength of the U.S.-Mozambique relationship, building on decades of health cooperation between Mozambique and the United States. The U.S. Government has provided early and ongoing support for Mozambique's response to the COVID-19 pandemic, including assistance valued at $62.5 million. This assistance includes 50 ventilators donated to the Mozambican Ministry of Health in 2020, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives. For more information on U.S. support for Mozambique's efforts to combat COVID-19, visit this link.

The United States is committed to leading the global COVID-19 response because it is the right thing to do and will make the world safer. The U.S. Government committed $4 billion to the COVAX Facility, becoming the largest donor to the global effort to vaccinate people around the world. The U.S. Government has also purchased one billion vaccines for low-income countries and donated 80 million vaccines from the United States' own supply. For more information on the U.S. government's new Covid commitments, visit this link.

In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.

Distributed by APO Group on behalf of U.S. Embassy in Mozambique.

.

(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

All news about JOHNSON & JOHNSON
04:33aCORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
09/24CORONAVIRUS : U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mo..
AQ
09/24JOHNSON & JOHNSON : Pennsylvania Jury Reportedly Finds Johnson & Johnson Baby Power Didn't..
MT
09/24CDC Recommends Booster Shots of Pfizer-BioNTech COVID-19 Vaccine for Older Adults, High..
MT
09/24JOHNSON & JOHNSON : United States Supreme Court Declines To Hear Talcum Powder Appeal
AQ
09/22JOHNSON & JOHNSON : Unit Signs Deal for HealthVerity Patient Data Platform
MT
09/22PRO BANKRUPTCY BRIEFING : J&J Beats Injury Lawyers on Talc Bankruptcy; Judge Questions Tal..
DJ
09/21JOHNSON & JOHNSON : Unit Collaborates With Persephone Biosciences On Stool Analysis
MT
09/21Shangula Rages Against West's Vaccine Nationalism
AQ
09/21Johnson & Johnson Data Shows COVID-19 Booster Shots 94% Effective Against Moderate to S..
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,0x
Yield 2021 2,54%
Capitalization 433 B 433 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,39x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 164,36 $
Average target price 185,83 $
Spread / Average Target 13,1%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211